Stay updated on Durvalumab + Tremelumab in LS-SCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page’s footer shows an updated ClinicalTrials.gov revision from v3.5.2 to v3.5.3, indicating a software/version update rather than any substantive modification to the study’s record history.
    Difference
    0.1%
    Check dated 2026-04-24T06:30:42.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:49:11.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T08:33:18.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added a new site revision entry (v3.4.3) and removed the previous revision entry (v3.4.2) in the page's version history.
    Difference
    0.1%
    Check dated 2026-03-12T02:43:02.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the Notice about government funding and the prior Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:26:33.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and NIH Clinical Center operating status. Updated the history page to Revision: v3.4.1 and removed the v3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:36:21.000Z thumbnail image

Stay in the know with updates to Durvalumab + Tremelumab in LS-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.